Beyond The Obvious: Managing Business Risks During Life Science M&A / Due Diligence

In the business press, discussions of mergers or acquisitions (M&A) invariably include percentages of deals that did not realize their expected value creation. Failure numbers, ranging from 60-80 percent, are surprisingly high.